BALL KRISTINE M
SEC insider (Form 3/4/5 filer). CIK 0001266163. Director at Enliven Therapeutics, Inc. (ELVN) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in BURLINGAME, CA.
Companies BALL KRISTINE M has filed insider reports for
- Enliven Therapeutics, Inc. (ELVN): Director
- Oruka Therapeutics, Inc. (ORKA): Director
BALL KRISTINE M
CIK: 0001266163
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Oct 14, 2026ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
23.4K shares- - Jun 2, 2026ORKA
Oruka Therapeutics, Inc.
AwardDirectStock Option (right to buy)
9.1K shares- - Jun 2, 2025ORKA
Oruka Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.5K shares-
1-3 of 3 transactions